Skip to main content
CML-CP: TKI discontinuation feasible at first as well as second attempt
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
CML-CP: TKI discontinuation feasible at first as well as second attempt
User login
Username
Password
Reset your password
Concept
Lead
score
Chronic Myelogenous Leukemia
1
1
Tyrosine Kinase Inhibitor
0
0.71
Leukemia
0
0.5
Remission
0
0.5
Tyrosine Kinase
0
0.5
Biologic Therapy
0
0.29
Specialty
Lead
score
Hematology-Oncology
1
1
Internal Medicine
0
1
Pharmacist
0
0.29
Edit Tags